<DOC>
	<DOCNO>NCT00389064</DOCNO>
	<brief_summary>The primary purpose study evaluate whether treatment ( SEROQUEL SR ) quetiapine fumarate sustain release ( SR ) 9 week compare placebo improve elderly patient generalise anxiety disorder . PLEASE NOTE : Seroquel SR Seroquel extend release ( XR ) refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Efficacy Safety Study Seroquel SR Treatment Generalised Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male female patient , 66 year old , document clinical diagnosis Generalised Anxiety Disorder ( GAD ) . Absence current episode major depression . The presence dementia mental disorder GAD . Serious suicidal risk , uncontrolled hypertension , substance alcohol abuse . A current diagnosis cancer current past diagnosis stroke .</criteria>
	<gender>All</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Generalised Anxiety Disorder</keyword>
	<keyword>GAD</keyword>
</DOC>